LoPriore Chase
SEC insider (Form 3/4/5 filer). CIK 0002136903. VP, Corp. Dev. at Hepion Pharmaceuticals, Inc. (HEPA). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2026. Located in RED BANK, NJ.
Companies LoPriore Chase has filed insider reports for
- Hepion Pharmaceuticals, Inc. (HEPA): Director, Officer, VP, Corp. Dev.
LoPriore Chase
CIK: 0002136903
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HEPA
Hepion Pharmaceuticals, Inc.
DirectorOfficer